GLSHQ (Gelesis Holdings) Total Operating Expense: $58.89 Mil (TTM As of Jun. 2023)


What is Gelesis Holdings Total Operating Expense?

Gelesis Holdings GLSHQ -99.00% Total Operating Expense is $58.89 Mil as of Jun. 2023.

Gelesis Holdings's Total Operating Expense for the three months ended in Jun. 2023 was $10.61 Mil. Gelesis Holdings's Total Operating Expense for the trailing twelve months (TTM) ended in Jun. 2023 was $58.89 Mil.

Gelesis Holdings Total Operating Expense Related Terms

Gelesis Holdings Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Gelesis Holdings's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gelesis Holdings Total Operating Expense Chart

Gelesis Holdings Annual Data
Trend Dec21 Dec22
Total Operating Expense
86.18 120.02

Gelesis Holdings Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only 38.54 20.96 14.83 12.49 10.61

Gelesis Holdings Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $58.89 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $58.89 Mil mean?
Gelesis Holdings (GLSHQ) has a Total Operating Expense of $58.89 Mil as of Jun. 2023. Total operating expense is the primary recurring expense associated with central operations. View historical data on Gelesis Holdings and its competitors.
Is Gelesis Holdings' Total Operating Expense too high?
Gelesis Holdings' current Total Operating Expense is $58.89 Mil.
How does Gelesis Holdings' Total Operating Expense compare to RBSH and PPCB?
Gelesis Holdings' Total Operating Expense of $58.89 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Gelesis Holdings and its competitors. Gelesis Holdings's current Total Operating Expense is $58.89 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gelesis Holdings stock overvalued right now?
Gelesis Holdings (GLSHQ) has a current Total Operating Expense of $58.89 Mil. The current Total Operating Expense is $58.89 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Gelesis Holdings (GLSHQ), the current Total Operating Expense is $58.89 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gelesis Holdings Business Description

Address 501 Boylston Street, Suite 6102, Boston, MA, USA, 02116
Gelesis Holdings Inc is a biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Its portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH), and Functional Constipation.